Amphastar Pharmaceuticals, Inc.
Health
Performance
7.5
Risk
Sell
Buy
Curious about the Scores? Learn more.

Amphastar Pharmaceuticals, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

18.07.2026
Respawned at 1 HP. Still fragile, but back in play.
18.07.2026
Off life support. Still risky, but slightly less scary.
09.05.2026
Momentum tanked. Clearly underperforming.
01.01.2026
Stability slipping. Financial grip’s not as firm as it was.
AMPH
Amphastar Pharmaceuticals, Inc.
19.30
-1.48%
7.5
Sell
Buy
Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Amphastar Pharmaceuticals, Inc. do? Business model and key facts

Get the full picture of Amphastar Pharmaceuticals, Inc.: what it builds, where it operates, and how it makes money.

Amphastar Pharmaceuticals, Inc. Profile

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees (FY): 1976

Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and proprietary pharmaceutical products, which include injectables, inhalants, and intranasal formulations. Its market presence extends across the United States, China, and France. Amphastar's operations are divided into two primary segments: Finished Pharmaceutical Products and Active Pharmaceutical Ingredients (API). The company's extensive product portfolio encompasses a variety of crucial medications. These feature Primatene Mist, an over-the-counter epinephrine inhaler for the temporary alleviation of mild asthma symptoms; Enoxaparin, a low molecular weight heparin utilized for the prevention and treatment of deep vein thrombosis; and Naloxone, an essential treatment for opioid overdose. Other significant offerings include emergency Glucagon injection kits; Cortrosyn, a diagnostic agent for adrenocortical insufficiency; and Amphadase, a bovine-sourced hyaluronidase injection that aids in the absorption and dispersion of other administered drugs. Amphastar additionally supplies Epinephrine injections for severe allergic reactions; various lidocaine products (such as a jelly for urological procedures and a topical solution for other applications); Phytonadione injection (Vitamin K1) for newborns; and specialized emergency syringe products for hospital use. Furthermore, the company provides Morphine injections for patient-controlled analgesia and Lorazepam injections for surgical and medical procedures. More advanced therapeutics consist of Neostigmine methylsulfate injection to manage myasthenia gravis and reverse muscle relaxant effects, and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Beyond its finished pharmaceutical goods, Amphastar also acts as a distributor for recombinant human insulin API and porcine insulin API. The company caters to a broad spectrum of healthcare providers, including hospitals, various care facilities, clinics, and physicians' offices.

shop
Company facts
Yongfeng Zhang
CEO
1976
Employees worldwide
shop
Performance
-9.6%
Last 12 months
-5.44%
Last 5 years
shop
Growth
$719.89M
Revenue year
$98.09M
Net income
shop
Valuation
$870.61M
Market Cap
12.75
Price/Earnings Ratio

Stocks related to Amphastar Pharmaceuticals, Inc.

Selected based on industry alignment and relative market positioning.

GUD.TO
Knight Therapeutics Inc.
9.68
-2.91%
3.1
Sell
Buy
Knight Therapeutics Inc.
PCRX
Pacira BioSciences, Inc.
25.59
-0.74%
3.2
Sell
Buy
Pacira BioSciences, Inc.
CRON
Cronos Group Inc.
2.78
-0.71%
5.8
Sell
Buy
Cronos Group Inc.
EVO
Evotec SE
1.95
-2.50%
9.0
Sell
Buy
Evotec SE
KMDA
Kamada Ltd.
7.01
-3.71%
4.0
Sell
Buy
Kamada Ltd.

Events and news impacting Amphastar Pharmaceuticals, Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

Amphastar Pharmaceuticals, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.